News Celebrating Rare Disease Day and 40 Years of the Orphan Drug Act Advocating for Rare Disease Patients and Their Families HERNDON, VA. (PRWEB) FEBRUARY 08, 2023 Global life expectancy has more than…Super UserFebruary 13, 2023
News Policy Changes Could Cut Short a Golden Age of Drug Development | RealClearPolicy 2022 was an incredibly productive year for American scientists. Biopharmaceutical researchers conducted…Super UserFebruary 13, 2023
News Issue Brief: March-In Rights Under the Bayh-Dole Act (February 2023) The biggest controversy surrounding the Bayh-Dole Act — which allows academic institutions…Super UserFebruary 13, 2023
News ApogeeBio Postdoctoral Programme Dear scientific community, The European programme ApogeeBio has launched the 2nd international…Super UserFebruary 13, 2023
News Baltimore’s KaloCyte Partners on $46M DARPA Program to Develop Synthetic Blood Product · BioBuzz KaloCyte’s experimental synthetic red blood cell product ErythroMer could provide a solution…Super UserFebruary 13, 2023
News Phlow Corp. Announces Formation of Business Advisory Board, New Board of Directors Appointment and Corporate President as Company Accelerates Towards Next Stage of Growth Richmond, Virginia, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Phlow Corp., a U.S.-based…Super UserFebruary 6, 2023
News Canon posts record revenues in medical business unit Stronger sales in Europe and the U.S. helped offset declining demand in…Super UserFebruary 6, 2023
News Cartesian Therapeutics Announces Dosing of First Participant in a Phase 2b Randomized Clinical Trial for Generalized Myasthenia Gravis – Cartesian ⦁ First placebo-controlled study of an engineered cell therapy Gaithersburg, MD, January…Super UserFebruary 6, 2023
News AURP BIO Health Caucus 2023 AURP’s BioHealth Caucus will examine topics, including: Economic impact of the biotech…Super UserFebruary 6, 2023
News Montgomery County Perfect Home for ARPA-H The newly established Advanced Research Projects Agency for Health (ARPA-H) will accelerate…Super UserFebruary 6, 2023